Eli Lilly’s weight loss drugs have delivered blockbuster sales in recent quarters. The company is a leader in this market ...

The underground selling of weight-loss drugs has exploded in line with the booming popularity of medications like Mounjaro ...

Biocon Limited has launched its GLP-1 peptide, liraglutide, for the treatment of diabetes and obesity in the Netherlands, as ...

One of the reasons for the internal disagreement at the club was the fact that the nutritionist Eduardo Rauen, who has been ...

Officers raided an address in the Llanrwst area following reports that prescription weight-loss drugs were being sold without ...

Caliway Biopharmaceuticals (TWSE: 6919), a clinical-stage biopharmaceutical company developing novel small-molecule therapeutics, announced that preclinical research involving CBL-514 was presented at ...

The Indian judiciary did well not to let Novo Nordisk extend its exclusive right to sell semaglutide, marketed as Ozempic and ...

Eli Lilly could extend its lead in its core therapeutic area with the launch of two new products next year. The company also ...

The first ‘real-world study’ into the weight loss drug, Mounjaro, has now started in Greater Manchester. Thousands of ...

The European Medicines Agency (EMA) has recommended extending the use of Mounjaro to younger patients with diabetes, ...

From shifting grocery habits to new product opportunities, Circana’s insights reveal how brands and retailers can adapt to ...

Obesity is a big driver of healthcare spending in South Africa, yet most medical schemes still limit cover for effective ...